The University of Chicago Header Logo

James L. LaBelle

Concepts (228)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Proto-Oncogene Proteins c-bcl-2
7
2023
190
2.440
Why?
Hematopoietic Stem Cell Transplantation
8
2023
878
2.170
Why?
Cell Death
3
2021
260
1.570
Why?
Peptides
7
2023
644
1.530
Why?
Neuroblastoma
4
2022
389
1.070
Why?
Apoptosis
10
2023
1703
0.990
Why?
Fetal Hemoglobin
1
2023
14
0.930
Why?
Stem Cell Transplantation
3
2022
185
0.920
Why?
Bcl-2-Like Protein 11
4
2020
23
0.900
Why?
CRISPR-Cas Systems
1
2023
70
0.880
Why?
Transplants
1
2023
42
0.880
Why?
Erythrocytes
1
2023
254
0.850
Why?
Lymphoma, Large B-Cell, Diffuse
1
2023
153
0.820
Why?
Nucleic Acids
1
2022
32
0.810
Why?
Forkhead Transcription Factors
1
2022
168
0.800
Why?
Anemia, Sickle Cell
1
2023
139
0.780
Why?
Bridged Bicyclo Compounds, Heterocyclic
1
2021
86
0.780
Why?
Myeloproliferative Disorders
1
2023
128
0.780
Why?
T-Lymphocytes
4
2023
1203
0.760
Why?
Immunotherapy
2
2017
646
0.710
Why?
Apoptosis Regulatory Proteins
4
2014
200
0.710
Why?
T-Lymphocytes, Regulatory
1
2022
298
0.700
Why?
Tumor Suppressor Protein p53
2
2023
400
0.690
Why?
Sulfonamides
1
2021
313
0.680
Why?
Mitochondrial Membranes
1
2019
14
0.670
Why?
Mitochondria
3
2020
542
0.660
Why?
Cathepsin B
1
2017
12
0.620
Why?
Reticulocytosis
1
2017
1
0.610
Why?
Anemia, Neonatal
1
2017
5
0.610
Why?
Proto-Oncogene Proteins
4
2014
653
0.590
Why?
Bilirubin
1
2017
130
0.590
Why?
Erythrocyte Transfusion
1
2017
71
0.570
Why?
Recovery of Function
1
2017
281
0.550
Why?
Thiamine
1
2015
8
0.530
Why?
Wernicke Encephalopathy
1
2015
6
0.530
Why?
Leukemia, Myeloid, Acute
3
2021
775
0.530
Why?
Hematologic Neoplasms
2
2023
333
0.510
Why?
Antineoplastic Agents
3
2023
2382
0.490
Why?
beta-Thalassemia
1
2013
6
0.470
Why?
Myeloablative Agonists
1
2013
36
0.470
Why?
Cyclophosphamide
1
2013
300
0.440
Why?
Antibodies, Monoclonal
3
2017
1393
0.440
Why?
Membrane Proteins
3
2014
1207
0.410
Why?
Cell Line, Tumor
5
2023
2494
0.410
Why?
Mice
11
2023
11577
0.400
Why?
Heart Diseases
1
2013
294
0.380
Why?
Neoplasms
2
2023
2966
0.380
Why?
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
2023
54
0.330
Why?
Animals
15
2023
26935
0.330
Why?
Drug Delivery Systems
2
2022
179
0.320
Why?
Child, Preschool
5
2017
3648
0.320
Why?
Humans
29
2023
87465
0.320
Why?
Protein Interaction Mapping
2
2017
82
0.290
Why?
Autografts
2
2017
28
0.290
Why?
Child
5
2023
7035
0.270
Why?
Killer Cells, Natural
2
2002
271
0.230
Why?
Hemoglobin, Sickle
1
2023
19
0.230
Why?
Antigens, CD34
1
2023
158
0.220
Why?
Immunotherapy, Adoptive
2
2022
183
0.220
Why?
Protein Conformation, alpha-Helical
1
2022
16
0.220
Why?
CD3 Complex
1
2002
134
0.210
Why?
Pharmaceutical Preparations
1
2023
91
0.210
Why?
B7-1 Antigen
1
2002
76
0.210
Why?
Antigens, Differentiation
1
2002
141
0.200
Why?
Immunity, Cellular
1
2002
178
0.200
Why?
Immunoconjugates
1
2002
106
0.200
Why?
Retinal Detachment
1
2022
66
0.200
Why?
T-Lymphocyte Subsets
2
2020
273
0.190
Why?
Lymphocyte Count
2
2020
94
0.190
Why?
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
2021
45
0.190
Why?
Graft vs Host Disease
2
2020
357
0.190
Why?
Leukemia, Myeloid
1
2002
249
0.190
Why?
Lymphocytosis
1
2020
10
0.180
Why?
Flow Cytometry
3
2019
686
0.180
Why?
Thymocytes
1
2020
30
0.180
Why?
Antigens, CD
1
2002
462
0.180
Why?
Promoter Regions, Genetic
1
2023
951
0.180
Why?
Infant
3
2017
3095
0.180
Why?
Palliative Care
1
2022
262
0.180
Why?
Membrane Glycoproteins
1
2002
430
0.180
Why?
Mice, Knockout
3
2020
1966
0.170
Why?
Permeability
1
2019
137
0.160
Why?
Homeostasis
1
2020
404
0.150
Why?
Reticulocyte Count
1
2017
2
0.150
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2022
393
0.150
Why?
Protein Interaction Maps
1
2017
48
0.150
Why?
Surface-Active Agents
1
2017
60
0.150
Why?
Up-Regulation
1
2020
725
0.150
Why?
Endosomes
1
2017
75
0.150
Why?
Fluorescence Resonance Energy Transfer
1
2017
94
0.150
Why?
Proteolysis
1
2017
102
0.150
Why?
DNA-Directed RNA Polymerases
1
2017
103
0.140
Why?
Endocytosis
1
2017
177
0.140
Why?
Proteins
1
2022
784
0.140
Why?
HeLa Cells
1
2017
503
0.140
Why?
Lipid Metabolism
1
2017
198
0.140
Why?
Nanoparticles
1
2017
161
0.140
Why?
Protein Transport
1
2017
417
0.140
Why?
Lipids
1
2017
268
0.130
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2023
2493
0.130
Why?
Disease-Free Survival
2
2022
1208
0.130
Why?
Gene Expression Regulation
1
2022
1956
0.120
Why?
Cyclin D1
1
2013
84
0.120
Why?
Lymphoma, Mantle-Cell
1
2013
37
0.110
Why?
Proto-Oncogene Proteins c-myc
1
2014
125
0.110
Why?
Graft vs Leukemia Effect
1
2013
11
0.110
Why?
Fatal Outcome
1
2013
295
0.110
Why?
Proto-Oncogene Proteins c-akt
1
2014
334
0.110
Why?
Immunophenotyping
4
2013
213
0.100
Why?
Allografts
1
2013
173
0.100
Why?
Skin
1
2015
561
0.100
Why?
Peptide Fragments
1
2014
459
0.100
Why?
Male
6
2017
41449
0.100
Why?
Neoplasm Transplantation
1
2012
396
0.100
Why?
Retrospective Studies
3
2022
8701
0.100
Why?
Protein Structure, Secondary
1
2012
330
0.100
Why?
Infant, Newborn
1
2017
2423
0.100
Why?
Extracorporeal Membrane Oxygenation
1
2013
170
0.100
Why?
Transplantation, Heterologous
1
2012
370
0.100
Why?
Myocardium
1
2013
560
0.090
Why?
Tumor Cells, Cultured
2
2002
1048
0.090
Why?
Recurrence
1
2013
1161
0.090
Why?
B-Lymphocytes
1
2013
729
0.080
Why?
Pulmonary Blastoma
1
2008
5
0.080
Why?
Disease Progression
1
2013
1473
0.080
Why?
BH3 Interacting Domain Death Agonist Protein
1
2008
13
0.080
Why?
Age Factors
1
2013
1847
0.080
Why?
Treatment Outcome
3
2022
8051
0.070
Why?
Bone Marrow Neoplasms
1
2007
18
0.070
Why?
Abdominal Neoplasms
1
2007
39
0.070
Why?
Pancreatitis
1
2007
87
0.070
Why?
Pleural Neoplasms
1
2008
191
0.070
Why?
CD8 Antigens
2
2002
81
0.060
Why?
CD4 Antigens
2
2002
83
0.060
Why?
Female
4
2017
45140
0.060
Why?
Adolescent
1
2017
9075
0.060
Why?
Receptors, Antigen, T-Cell, alpha-beta
2
2002
99
0.060
Why?
Leukemia, T-Cell
1
2004
17
0.060
Why?
Leukemia, Lymphoid
1
2004
72
0.060
Why?
Antibodies, Neoplasm
1
2004
84
0.060
Why?
Time Factors
1
2013
5258
0.060
Why?
bcl-X Protein
1
2023
53
0.060
Why?
Myeloid Cell Leukemia Sequence 1 Protein
1
2023
35
0.060
Why?
Mice, Inbred C57BL
3
2013
3160
0.060
Why?
HEK293 Cells
2
2017
629
0.060
Why?
Melphalan
1
2023
98
0.050
Why?
Adult
2
2022
25988
0.050
Why?
Prospective Studies
2
2022
4230
0.050
Why?
B7-2 Antigen
1
2002
40
0.050
Why?
Risk Factors
1
2013
5365
0.050
Why?
Abatacept
1
2002
85
0.050
Why?
Cell- and Tissue-Based Therapy
1
2022
49
0.050
Why?
CTLA-4 Antigen
1
2002
137
0.050
Why?
Cytotoxicity, Immunologic
1
2002
212
0.050
Why?
Signal Transduction
3
2023
3327
0.050
Why?
Induction Chemotherapy
1
2022
148
0.050
Why?
Neoplasm, Residual
1
2022
170
0.050
Why?
bcl-2-Associated X Protein
2
2013
48
0.050
Why?
Models, Molecular
2
2017
1288
0.050
Why?
Transplantation, Autologous
1
2022
340
0.050
Why?
Cell Division
1
2002
695
0.050
Why?
Transfection
1
2002
907
0.050
Why?
Leukocyte Transfusion
1
1999
15
0.050
Why?
Receptors, Antigen, T-Cell
1
2002
382
0.040
Why?
Chimerism
1
2020
36
0.040
Why?
Drug Resistance, Neoplasm
1
2023
608
0.040
Why?
Protein Structure, Tertiary
2
2013
738
0.040
Why?
Inpatients
1
2022
306
0.040
Why?
Cytokines
1
2002
794
0.040
Why?
Protein Binding
1
2002
1474
0.040
Why?
CD8-Positive T-Lymphocytes
1
2002
581
0.040
Why?
Solutions
1
2017
85
0.040
Why?
Transplantation Conditioning
1
2020
371
0.040
Why?
Transplantation, Homologous
1
2020
994
0.040
Why?
Healthcare Disparities
1
2022
386
0.040
Why?
Drug Carriers
1
2017
82
0.040
Why?
Biosensing Techniques
1
2017
73
0.040
Why?
Neoplasm Recurrence, Local
1
2023
1343
0.030
Why?
RNA, Messenger
1
2002
1994
0.030
Why?
Regenerative Medicine
1
2016
24
0.030
Why?
Drug Design
1
2016
124
0.030
Why?
Nanostructures
1
2016
77
0.030
Why?
Lung Neoplasms
1
2008
2308
0.030
Why?
Biocompatible Materials
1
2016
196
0.030
Why?
Prognosis
1
2022
3706
0.030
Why?
Caspase 7
1
2013
15
0.030
Why?
Immunoenzyme Techniques
1
2013
305
0.030
Why?
Quinolines
1
2014
90
0.030
Why?
Porosity
1
2013
60
0.030
Why?
Imidazoles
1
2014
150
0.030
Why?
Caspase 3
1
2013
160
0.030
Why?
Phosphatidylinositol 3-Kinases
1
2014
265
0.030
Why?
Substrate Specificity
1
2013
350
0.030
Why?
Enzyme Activation
1
2013
694
0.030
Why?
Cell Cycle
1
2013
506
0.030
Why?
Proteomics
1
2013
221
0.030
Why?
Zebrafish
1
2014
310
0.020
Why?
Mice, Transgenic
1
2013
1563
0.020
Why?
Amino Acid Sequence
1
2013
2061
0.020
Why?
United States
1
2022
6763
0.020
Why?
MicroRNAs
1
2014
542
0.020
Why?
Molecular Sequence Data
1
2013
3028
0.020
Why?
Fluorescence Polarization
1
2008
9
0.020
Why?
Fluorescein-5-isothiocyanate
1
2008
24
0.020
Why?
Annexin A5
1
2008
20
0.020
Why?
Cytochromes c
1
2008
27
0.020
Why?
Dextrans
1
2008
77
0.020
Why?
Liposomes
1
2008
92
0.020
Why?
Pneumonectomy
1
2008
202
0.020
Why?
Acute Disease
1
2007
832
0.020
Why?
Alemtuzumab
1
2004
84
0.010
Why?
Combined Modality Therapy
1
2007
1695
0.010
Why?
Mice, Inbred AKR
1
1999
10
0.010
Why?
Thy-1 Antigens
1
1999
16
0.010
Why?
Radiation Chimera
1
1999
23
0.010
Why?
Lymphocyte Depletion
1
1999
97
0.010
Why?
Histocompatibility Testing
1
1999
138
0.010
Why?
Major Histocompatibility Complex
1
1999
82
0.010
Why?
Genetic Predisposition to Disease
1
2008
2306
0.010
Why?
T-Lymphocytes, Helper-Inducer
1
1999
134
0.010
Why?
Thymus Gland
1
1999
195
0.010
Why?
Isoantibodies
1
1999
117
0.010
Why?
Spleen
1
1999
430
0.010
Why?
T-Lymphocytes, Cytotoxic
1
1999
316
0.010
Why?
Antibodies, Monoclonal, Humanized
1
2004
942
0.010
Why?
Lymphocyte Activation
1
1999
737
0.010
Why?
Cell Differentiation
1
1999
1501
0.010
Why?
Middle Aged
1
2004
25302
0.000
Why?
LaBelle's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (228)
Explore
_
Co-Authors (41)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_